Inhibition of NRP-1 function may also result in modulation of signal transduction pathways triggered by growth factors other than VEGF-A, such as PDGF, FGF, EGF, and HGF, which are implicated in tumor progression and are capable of binding NRP-1. The gene discussed is EGF; the disease is neoplasm.